Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 50Infertility 21Anovulation 10Vitamin D Deficiency 2Rare Diseases 2Hyperinsulinism 2Hyperandrogenism 2Endocrine System Diseases 2Prolactinoma 1Primary Ovarian Insufficiency 1Pathologic Processes 1Motor Activity 1Leiomyoma 1Insulin Resistance 1Infertility, Female 1Hypogonadism 1Hyperprolactinemia 1

Interventions

Metformin 2Leuprolide 2Collagenases 2Clomiphene 2tremelimumab 1durvalumab 1Temozolomide 1Streptozocin 1Spironolactone 1Specimen Handling 1Radiosurgery 1Radiation 1Propofol 1Prednisone 1Plasma Exchange 1Nivolumab 1Midazolam 1Mercaptopurine 1Melphalan 1Magnetic Resonance Spectroscopy 1Irinotecan 1Ipilimumab 1Infliximab 1Immunoglobulins 1High-Throughput Nucleotide Sequencing 1Fentanyl 1FANG vaccine 1Cyclophosphamide 1Clomipramine 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Rare Diseases × Clomiphene × Clear all
NCT00005104 2005-06-24

Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome

National Center for Research Resources (NCRR)

Phase NA Completed
99 enrolled

Endocrine System Diseases, Hyperinsulinism, Polycystic Ovary Syndrome, Rare Diseases

NCT00005654 2005-06-24

Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome

Office of Rare Diseases (ORD)

Phase NA Completed
88 enrolled

Endocrine System Diseases, Hyperinsulinism, Polycystic Ovary Syndrome, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡